What did @riki.tyminski actually say?
Riki describes a year-long slide into fatigue, irregular periods, hair loss, brain fog, and anxiety starting in summer 2023. She saw a gynecologist, a primary care physician, and an endocrinologist. All three told her results were normal and that symptoms were stress or aging. A telehealth platform ordered what she calls "the full blood panel" and found she was "pretty much low on every hormone" including testosterone, progesterone, and estrogen. That same workup flagged an underactive thyroid, which she says had been missed entirely. She is now on thyroid medication and hormone replacement therapy. Her core message: if your doctors dismiss you, keep looking.
This is a personal health narrative, not a clinical recommendation. She names no specific lab values, no doses, and no diagnoses beyond hypothyroidism. That restraint actually matters when evaluating what she got right and wrong.
Does the science back this up?
The symptoms she lists, including fatigue, hair loss, irregular cycles, weight fluctuation, and cognitive difficulty, are consistent with both hypothyroidism and low androgen states in women. The frustrating part is that standard panels often miss subclinical versions of both.
Hypothyroidism is genuinely underdiagnosed in women of reproductive age. A 2017 review by Garber et al. in Thyroid estimated that TSH-only screening misses a meaningful subset of symptomatic patients when free T4 and T3 are not evaluated. Hair loss, in particular, is a classic presentation of thyroid dysfunction and is frequently attributed to stress before labs are ordered.
Female testosterone deficiency is murkier territory. The Endocrine Society does not recognize a formal "female androgen deficiency syndrome" as a diagnosable condition (Wierman et al., 2014, Journal of Clinical Endocrinology and Metabolism). Low testosterone in women correlates with reduced libido and fatigue in some studies, but population reference ranges for women are poorly standardized. So the claim that she was "low" on testosterone is plausible but hard to verify without knowing which assay and which reference range was used.
Estrogen and progesterone deficiencies in a pre-menopausal woman with irregular cycles are clinically coherent. That is not controversial.
What did they get wrong (or right)?
She gets credit for one thing most health influencers skip: she describes a diagnostic process, not just a product. She got labs. She saw multiple providers. She did not open the video claiming a supplement fixed her.
The phrase "low on every hormone" is where things get slippery. That framing implies a clean, objective deficiency across the board, but hormone reference ranges vary significantly by lab, cycle phase, and assay methodology. A woman tested on day 21 of her cycle will show very different progesterone than one tested on day 7. Without those specifics, "low on every hormone" is more of a narrative convenience than a clinical statement.
She also implies that telehealth providers are categorically more thorough than traditional physicians because they ordered the "full panel without question." That may have been her experience, but it is not a systemic truth. Some telehealth platforms order extensive panels because their business model incentivizes treatment; that is not always the same as better medicine. Patients should know the difference between comprehensive care and comprehensive billing.
Her thyroid discovery is the most clinically credible part of this video. Missing hypothyroidism in a symptomatic woman is a documented gap in standard care.
What should you actually know?
If you relate to her symptom list, a few things are worth understanding before booking a telehealth hormone consult.
- Thyroid panels vary. A TSH alone is not the same as TSH plus free T4, free T3, and thyroid antibodies. Ask specifically what your doctor ordered.
- Female testosterone testing is not standardized. The assays most labs use were designed for male reference ranges. Wierman et al. (2014) specifically flagged this as a problem for clinical decision-making in women.
- Hormone symptoms overlap heavily with other conditions including iron-deficiency anemia, sleep apnea, perimenopause, and ADHD. A full workup should rule those out, not just chase a hormone number.
- Telehealth platforms vary significantly in clinical rigor. Some employ board-certified endocrinologists. Others use nurse practitioners with limited endocrine training. Asking about provider credentials and what guidelines they follow is reasonable before starting any hormone therapy.
- HRT for pre-menopausal women with documented deficiencies is supported by evidence. HRT as general "optimization" for women with borderline labs is a different and less settled question.
Her takeaway, "if it doesn't feel right, keep searching," is genuinely good advice. Self-advocacy in women's healthcare has strong evidence behind it as a necessity, not a preference. Just make sure the provider you land on is doing rigorous diagnostics, not just ordering every test available to justify a prescription.